Clinical Trials Browser

Adjuvant Drug Therapy

Breast Neoplasms

Neuroendocrine Tumors

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Advanced Rectal Cancer

Breast Neoplasm Malignant Female

Gastrointestinal Neoplasms

Locally Advanced Gastric Cancer

Rectal Neoplasms

Brain Neoplasms, Glioblastoma, Neoplasms

Childhood Solid Tumor

Esophageal Neoplasms

Breast Neoplasms

Colonic Neoplasms

Colorectal Cancer Metastatic

Breast Neoplasms, Triple Negative Breast Neoplasms

Nasopharyngeal Carcinoma

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Breast Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Solid Tumors

Pancreatic Neoplasms

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Rectal Neoplasms

Nasopharangeal Cancer

Colonic Neoplasms

Spinocerebellar Degenerations

Pancreatic Neoplasms

Rectal Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Clinical Trials

STARTER

Capecitabine in ER+/HER2-negative Breast Cancer

CapTemY90

RAIRI-NPC

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer

DPDMAX

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

K-BOOST

CAPTEM

Metro-PD1

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

ORCHID

OPTICAL

TriComB

EVOLVE-BDT

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

GRECCAR12

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Neo-CD

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

MAIBE

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

JS212 Combination Therapies in Metastatic Colorectal Cancer

LAP100

Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer

TNTIT

CLEAR-01

CLEAR-02

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

CASINOs

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

TORCH-STAR

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

JAZMINE

SASCIA

EC-CRT-008